Progesterone capsule and preparation method thereof
A progesterone and capsule technology, which is applied in the directions of capsule delivery, pharmaceutical formulations, and non-active ingredients medical preparations, can solve the problems of harsh preparation process conditions, increase the economic burden of patients, and add complex components, and reduce the economic burden, The effect of reducing production cost and easy preparation
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- Publication Date
- 2021-06-22
Abstract
Description
technical field
[0001] The invention relates to the technical field of medicine preparation, in particular to a progesterone capsule and a preparation method. Background technique
[0002] Progesterone, also known as progesterone hormone and luteinizing hormone, is the main biologically active progesterone secreted by the ovary. Progesterone can protect the endometrium of women. During pregnancy, progesterone hormone can provide support and protection for the early growth and development of the fetus, and can play a certain calming effect on the uterus. In addition, the relationship between progesterone and estrogen is inseparable, and both are very important female hormones. The function of estrogen is mainly to promote the development and maturation of female secondary sexual characteristics, while the progesterone hormone further promotes the development and maturation of secondary sexual characteristics on the basis of the action of estrogen, and there is a synergistic ...
Examples
no. 1 example
[0064] A preparation method for progesterone capsules, comprising the steps of:
[0065] (1) Preparation of progesterone powder:
[0066] (a): primary mix:
[0067] S1: Firstly, sterilize various raw materials. You can choose 200,000 rad (50.16C / kg) irradiation dose for irradiation sterilization.
[0068] S2: Inject 25% of acetone solvent into the sterilized reaction kettle and heat it to 50°C. During the heating process, slowly stir the acetone solvent to make it evenly heated, and add 45% of the carrier to the acetone solvent Glyceryl monostearate;
[0069] S3: Add 15% progesterone, an active drug ingredient, into the acetone solvent in the reaction kettle, and continue stirring;
[0070] S4: Put 2% sodium octadecyl sulfate into the reaction kettle, continue stirring to dissolve it;
[0071] S5: taking out the mixed solution in the reactor for use;
[0072] (b): dry crushing treatment
[0073] Q1: Dry the reserved mixed solution from (a) S5 through a vacuum dryer;
[...
no. 2 example
[0088] A preparation method for progesterone capsules, comprising the steps of:
[0089] (1) Preparation of progesterone powder:
[0090] (a): primary mix:
[0091] S1: Firstly, sterilize various raw materials. You can choose 200,000 rad (50.16C / kg) irradiation dose for irradiation sterilization.
[0092] S2: Inject 15% acetone solvent into the sterilized reaction kettle and heat it to 50°C. During the heating process, slowly stir the acetone solvent to make it evenly heated, and add 35% of the carrier to the acetone solvent Glyceryl monostearate;
[0093] S3: Add 35% of the active drug ingredient progesterone into the acetone solvent in the reaction kettle, and continue stirring;
[0094] S4: Put 4% sodium octadecyl sulfate into the reaction kettle, continue stirring to dissolve it;
[0095] S5: taking out the mixed solution in the reactor for use;
[0096] (b): dry crushing treatment
[0097] Q1: Dry the reserved mixed solution from (a) S5 through a vacuum dryer;
[0...
no. 3 example
[0112] A preparation method for progesterone capsules, comprising the steps of:
[0113] (1) Preparation of progesterone powder:
[0114] (a): primary mix:
[0115] S1: Firstly, sterilize various raw materials. You can choose 200,000 rad (50.16C / kg) irradiation dose for irradiation sterilization.
[0116] S2: Inject 20% of acetone solvent into the sterilized reaction kettle and heat it to 50°C. During the heating process, slowly stir the acetone solvent to make it evenly heated, and add 40% of the carrier to the acetone solvent Glyceryl monostearate;
[0117] S3: Add 25% of the active drug ingredient progesterone into the acetone solvent in the reaction kettle, and continue stirring;
[0118] S4: Put 3% sodium octadecyl sulfate into the reaction kettle, continue stirring to dissolve it;
[0119] S5: taking out the mixed solution in the reactor for use;
[0120] (b): dry crushing treatment
[0121] Q1: Dry the reserved mixed solution from (a) S5 through a vacuum dryer;
...